$INSY Insys filed for chapter 11 bankruptcy with plans to sell its assets, just days after agreeing to pay $225 million to settle federal charges over sales of its opioid drug Subsys.
The U.S. Justice Department tops the list of Insys' unpaid creditors, but the bankruptcy filing means it almost certainly won't collect in full.